GURUFOCUS.COM » STOCK LIST » USA » NYSE » Danaher Corp (NYSE:DHR) » Definitions » GF Value Rank
Switch to:

Danaher GF Value Rank

: 6 (As of Today)
View and export this data going back to 1986. Start your Free Trial

Danaher has the GF Value Rank of 6.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison

For the Diagnostics & Research subindustry, Danaher's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Danaher GF Value Rank Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Danaher's GF Value Rank falls into.



Danaher GF Value Rank Related Terms

Thank you for viewing the detailed overview of Danaher's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher Business Description

Danaher logo
Address
2200 Pennsylvania Avenue, North West, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Executives
Couchara Georgeann officer: SVP, Human Resources 2200 PENNSYLVANIA AVENUE, NW SUITE 800W WASHINGTON DC 20037
Bouda Christopher officer: VP, Chief Accounting Officer 2200 PENNSYLVANIA AVENUE, NW SUITE 800W WASHINGTON DC 20037
Sanders A Shane director 2200 PENNSYLVANIA AVENUE, NW SUITE 800W WASHINGTON DC 20037
Honeycutt Jennifer officer: Executive Vice President 2200 PENNSYLVANIA AVENUE SUITE 800W WASHINGTON DC 20037
Gutierrez-ramos Jose-carlos officer: SVP, Chief Scientific Officer C/O MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Mega Jessica L director 2200 PENNSYLVANIA AVENUE SUITE 800W WASHINGTON DC 20037
Sabeti Pardis C director 2200 PENNSYLVANIA AVENUE SUITE 800W WASHINGTON DC 20037
Mcgrew Matthew officer: EVP & Chief Financial Officer 2200 PENNSYLVANIA AVENUE, NW SUITE 800 W WASHINGTON DC 20010
Weidemanis Joakim officer: Executive Vice President 2200 PENNSYLVANIA AVENUE SUITE 800W WASHINGTON DC 20037
Rales Steven M director, officer: Chairman 2200 PENNSYLVANIA AVENUE, NW SUITE 800W WASHINGTON DC 20037
Stevens Raymond C director 2200 PENNSYLVANIA AVENUE SUITE 800W WASHINGTON DC 20037
Blair Rainer officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, NW SUITE 800W WASHINGTON DC 20037
Hugin Robert J director C/O THE MEDICINES CO 8 CAMPUS DR PARSIPPANY NJ 07054
Ellis Brian W officer: Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW WASHINGTON DC 20037
Rales Mitchell P director, officer: Chairman of Exec. Committee 11790 GLEN ROAD POTOMAC MD 20854

Danaher Headlines

From GuruFocus

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)